# Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/randomized-double-blind-trial-of-glial-cell-line-derived-neurotrophic-factor/

## Facts

| Field | Value |
| --- | --- |
| Author Names | John G. Nutt,Kim J. Burchiel,Cynthia Comella,Joseph Jankovic,Anthony E. Lang,Edward R. Laws,Andrés M. Lozano,R. D. Penn,Richard K. Simpson,Mark Stacy,G. F. Wooten,the ICV GDNF Study Group* |
| Citations | 823 |
| DOI | 10.1212/wnl.60.1.69 |
| Fields | Medicine,Neuroscience |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2165526364 |
| PMID | 12525720 |
| Type | article |
| Year | 2003 |

## Paper authors

- [Kim J. Burchiel](https://scholariq.org/researchers/kim-j-burchiel/)

## Paper journal

- [Neurology](https://scholariq.org/journals/neurology/)

## Paper primary topic

- [Nerve injury and regeneration](https://scholariq.org/topics/nerve-injury-and-regeneration/)

## Paper topics

- [Nerve injury and regeneration](https://scholariq.org/topics/nerve-injury-and-regeneration/)
- [Neurogenesis and neuroplasticity mechanisms](https://scholariq.org/topics/neurogenesis-and-neuroplasticity-mechanisms/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.